A synthetic antioxidant developed by researchers improves the survival of islet cells used in transplants for diabetes.
New findings in clinical and basic science transplantation research to be presented; results of a study that treated diabetic children with a combination of cells from a pig’s pancreas and testes, and findings from three separate studies with a common goal in mind: to wean organ transplant patients off all anti-rejection drugs less than one year after transplantation, defying the tenet that such drugs are required for life.
A newly discovered gene plays a dramatic role in diabetes among rats, and is also present in nearly identical form in humans.
Researchers a step closer to the goals of preventing type 1 diabetes and of preserving insulin production in people newly diagnosed with the disease.
Researchers have halted the course of early stage Type 1 diabetes for a year by treating patients for just two weeks with a new immune-suppressive drug, which only had minor side effects.
Researchers at Stanford University Medical Center have created fruit flies with a condition that mimics human diabetes.
A special type of dendritic cell unusual for its capacity to promote the swift death of T cells appears to prevent diabetes.